PBMs’ Medicare Formulary Lobbying Takes On New Dimensions
Executive Summary
The Pharmaceutical Care Management Association's efforts to ensure the Medicare model formulary guidelines will enable pharmacy benefit managers to negotiate deep discounts on drugs have expanded to include print advertising and direct appeals to the Centers for Medicare & Medicaid Services
You may also be interested in...
Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say
Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said
Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say
Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said
Rx Industry Supports “Reasonable” Tiered Copays, PhRMA CEO Says
The pharmaceutical industry agrees that "reasonable" tiering of prescription drug copays is an appropriate way to encourage cost-consciousness by consumers, Pharmaceutical Research & Manufacturers of America CEO Alan Holmer told the Pharmaceutical Compliance Congress Nov. 16 in Washington, D.C